Trial description:
A Phase III Randomized, Double-Blind Placebo Controlled, Multi-Regional, International Study of Durvalumab in Combination with Gemcitabine Plus Cisplatin Versus Placebo in Combination with Gemcitabine Plus Cisplatin for Patients With First-Line Advanced Biliary Tract Cancers
Contact name:
Dr Pippa Corrie
Trial start date:
Tuesday, June 18, 2019
Trial end date:
Friday, November 20, 2020
Trial tumour type:
Liver & Bile Duct
Show on Radiotherapy:
No
